NYSE ARCA | ETF
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
NK | NantKwest Inc | Healthcare | Biotechnology | 7.94% |
MRNA | Moderna Inc | Healthcare | Biotechnology | 7.58% |
DGX | Quest Diagnostics Incorporated | Healthcare | Diagnostics & Research | 7% |
BNTX | BioNTech SE | Healthcare | Biotechnology | 6.19% |
ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 6.11% |
LH | Laboratory Corporation of America Holdings | Healthcare | Diagnostics & Research | 5.92% |
DVAX | Dynavax Technologies Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.64% |
IMCR | Immunocore Holdings Ltd | Healthcare | Biotechnology | 3.61% |
QL1A | QUIDELORTHO DL-001 | Healthcare | Medical Devices | 3.6% |
BIO | Bio-Rad Laboratories Inc | Healthcare | Medical Devices | 3.55% |
PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 3.45% |
ZLAB | Zai Lab Ltd | Healthcare | Biotechnology | 3.21% |
ABCL | Abcellera Biologics Inc | Healthcare | Biotechnology | 2.99% |
VIR | Vir Biotechnology Inc | Healthcare | Biotechnology | 2.77% |
OPK | Opko Health Inc | Healthcare | Diagnostics & Research | 2.35% |
BCRX | BioCryst Pharmaceuticals Inc | Healthcare | Biotechnology | 2.16% |
ARCT | Arcturus Therapeutics Holdings Inc | Healthcare | Biotechnology | 1.75% |
ICVX | Icosavax Inc | Healthcare | Biotechnology | 1.66% |
HLVX | Hillevax Inc | Healthcare | Biotechnology | 1.58% |
SIGA | SIGA Technologies Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.54% |
Under normal circumstances, the fund invests at least 80% of its net assets in U.S.-listed equity securities or ADRs of Treatments, Testing and Advancements Companies. In general, the index seeks to be comprised of companies performing advancements in research, development, and commercialization of treatments or vaccines for infectious diseases, or engaged in the advancement of research, development, manufacturing, and provision of biological tests for patients. The fund is non-diversified.